Sanofi Ventures
CVC · Cambridge, MA · United States
Stages
Investment region
Industries
Profile
Sanofi Ventures is a strategic venture fund based in France, launched by the pharmaceutical giant Sanofi. They are an early-stage investor focusing on transformational science and technology in the biotech and digital health sectors. The team is composed of experienced professionals such as Jason P. Hafler (Managing Director), Laia Crespo (Partner), and Cris De Luca (Partner) among others. The firm separates itself by providing strategic insights and long-term support to its portfolio companies, drawing from its deep industry knowledge as part of Sanofi. Sanofi Ventures invests in top-tier biotech and digital health firms that aim to enhance patient care and transform medical practices. They participate across various stages, including Seed to Series B, frequently leading financings and holding board positions. Although specific check sizes aren't disclosed, their strategic partnership with Sanofi suggests significant resources could be deployed. They seek opportunities worldwide but with a strategic alignment to Sanofi’s corporate goals. Notable portfolio companies include Memento Medicines (biotherapeutic development), Bionyra (health innovation), BranchLab (biotech tools), QuantHealth (AI-powered digital twins), Fulcrum Therapeutics (muscular dystrophy therapy), and i2O Therapeutics (nanobody medicine delivery). These investments reflect their focus on cutting-edge solutions in biotechnology and digital health sectors.
Contatos (4)
| Name | Title | Telefone | ||
|---|---|---|---|---|
| — | — | |||
| Director of Investments | — | — | — | |
| Managing Director | — | — | — | |
| Head of Europe |
Name, email and phone are partially hidden. Subscribe to see them in full.